In this episode:
00:00 – Introduction by Paul Rickard
01:32 – Peter Switzer on why it’s time to get more defensive, how to position your portfolio, and the latest on the US market pullback
09:33 – Besa Deda (William Buck) on interest rates: are rate cuts finished, could a hike be next, and what’s driving sticky inflation? Property and share market outlook, plus how to invest for the next 12 months
Get the full story behind the latest stock market pullback—and how you can position your portfolio defensively in uncertain times. Paul Rickard and guests break down why the markets have turned cautious, whether rate cuts are finished, and what it all means for shares, property, and your money.
On this episode, our guests include Paul Rickard, Charlie Aitken, Paul Myliotis and Ying Yi Ann Cheng.
Get your weekly update on the big money stories and how they affect you with Peter Switzer and Paul Rickard.
Peter Switzer speaks to Julia Lee from Burman Invest, Michael Gable from Fairmont Equities, Adam Dawes from Shaw and Partners and Paul Rickard.
Dr Ross Walker explores the many health problems that can arise due to consuming processed foods.
On this episode, Peter Switzer is joined by Rudi Filapek-Vandyck from FNArena, Marcus Bogdan from the Switzer Dividend Growth Fund and Charles Tarbey from Century 21.
Tune in to our weekly show with Peter Switzer and Paul Rickard about the latest money stories and how they affect you.
Peter Switzer is joined by Julia Lee from Burman Invest, Jun Bei Liu from Tribeca and Paul Rickard from Switzer.
Dr Ross Walker takes a look at processed food and its connection with health problems such as cardiovascular disease, dementia and death.
What's making news in the world of money today? Find out from Peter Switzer and Paul Rickard!
Julia Lee from Burman Invest, Robbie Cooke from Tyro, Adam Dawes from Shaw and Partners, and Paul Rickard from Switzer join the show.
Dr Ross Walker's final segment on the decades looks at how one should look after their bodies after the age of 60.
Steven Yatomi-Clarke, the CEO & Managing Director of Prescient Therapeutics (PTX), speaks to Peter Switzer.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox
